F. Dol

1.2k citations

36 papers · 922 indexed · h-index 17

Impact in

Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
Hematology top 2%
- Blood Coagulation and Thrombosis Mechanisms
- Platelet Disorders and Treatments

Papers in ⓘ

Cell Biology 16
- Proteoglycans and glycosaminoglycans research 16
Hematology 14
- Blood Coagulation and Thrombosis Mechanisms 9
- Platelet Disorders and Treatments 8

Co-authors: Jean‐Marc Herbert (12 shared papers)Isabelle Lamarche (3 shared papers)Piérre Siè (17 shared papers)B Boneu (17 shared papers)Pierre Savi (5 shared papers)A. Bernat (5 shared papers)D. Dupouy (9 shared papers)Jean-P. Hérault (2 shared papers)
Journals: Thrombosis and Haemostasis (10 papers)Thrombosis Research (5 papers)FEBS Letters (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Blood Coagulation & Fibrinolysis (1 paper)
Partner nations: France India Canada

In The Last Decade

F. Dol

36 papers receiving 865 citations

Peers

Countries citing papers authored by F. Dol

Since Specialization

Citations

This map shows the geographic impact of F. Dol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Dol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Dol more than expected).

Fields of papers citing papers by F. Dol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Dol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Dol. The network helps show where F. Dol may publish in the future.

Co-authors

The 25 scholars most cited alongside F. Dol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with F. Dol Line = papers co-authored together F. Dol links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel Biochemical Pharmacology ·Pierre Savi, Jean‐Marc Herbert, A. M. Pflieger, F. Dol, Denis Delebassée, Jean Combalbert, G. Defreyn, Jean‐Pierre Maffrand	1992	161
2	DX 9065A a novel, synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studies. Journal of Pharmacology and Experimental Therapeutics ·Jean‐Marc Herbert, A. Bernat, F. Dol, Jean-P. Hérault, B. Crepon, J C Lormeau	1996	80
3	Induction of vascular smooth muscle cell growth by selective activation of the thrombin receptor Effect of heparin FEBS Letters ·Jean‐Marc Herbert, Isabelle Lamarche, F. Dol	1992	69
4	IL‐4 and IL‐13 exhibit comparable abilities to reduce pyrogen‐induced expression of procoagulant activity in endothelial cells and monocytes FEBS Letters ·Jean‐Marc Herbert, Pierre Savi, M.-Cl. Laplace, A. Lalé, F. Dol, A. Dumas, C. Labit, A Minty	1993	67
5	Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo. Journal of Clinical Investigation ·Jean‐Marc Herbert, Françoise Bono, J. Hérault, Corinne Avril, F. Dol, Anne-Marie Marés, Paul Schaeffer	1998	64
6	Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells. Journal of Biological Chemistry ·Jean‐Marc Herbert, Isabelle Lamarche, V. Prabonnaud, F. Dol, Thierry Gauthier	1994	62
7	Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells American Journal of Physiology-Heart and Circulatory Physiology ·C. Serradeil‐Le Gal, Jean‐Marc Herbert, Chantal Delisée, Paul Schaeffer, Danielle Raufaste, Corine Garcia, F. Dol, E. Marty, J.P. Maffrand, G. Le Fur	1995	48
8	Effect of Clopidogrel on Thrombin Generation in Platelet-Rich Plasma in the Rat Thrombosis and Haemostasis ·Jean-P. Hérault, F. Dol, C Gaich, A. Bernat, J. M. Herbert	1999	45
9	A Simple Method to Measure Dermatan Sulfate at Sub-Microgram Concentrations in Plasma Thrombosis and Haemostasis ·D. Dupouy, Piérre Siè, F. Dol, B Boneu	1988	41
10	Inactivation of heparin cofactor II by polymorphonuclear leukocytes Thrombosis Research ·Piérre Siè, D. Dupouy, F. Dol, B Boneu	1987	26
11	Effects of increased sulfation of dermatan sulfate on its in vitro and in vivo pharmacological properties Thrombosis Research ·F. Dol, C. Caranobe, D. Dupouy, Maurice Petitou, J C Lormeau, J Choay, Piérre Siè, B Boneu	1988	24
12	Potentiating Effect of Clopidogrel and SR 46349, a Novel 5-HT2 Antagonist, on Streptokinase-Induced Thrombolysis in the Rabbit Thrombosis and Haemostasis ·Jean‐Marc Herbert, A. Bernat, M. Sainte-Marie, F. Dol, Murielle L. Rinaldi	1993	21
13	The Consumption of Antithrombin III During Coagulation, Its Consequences for the Calculation of Prothrombinase Activity and the Standardisation of Heparin Activity Thrombosis and Haemostasis ·Suzette Beguı́n, H. Kessels, F. Dol, H.C. Hemker	1992	21
14	Pharmacodynamics and pharmacokinetics of dermatan sulfate in humans Blood ·F. Dol, Georges Houin, M Rostin, JL Montastruc, D. Dupouy, F Gianese, Piérre Siè, B Boneu	1989	19
15	Antithrombotic Activity of SR 46349, a Novel, Potent and Selective 5-HT2 Receptor Antagonist Thrombosis and Haemostasis ·Jean‐Marc Herbert, A. Bernat, Gérard Barthélémy, F. Dol, Murielle L. Rinaldi	1993	19
16	Pharmacokinetics of Heparin and Related Polysaccharidesa Annals of the New York Academy of Sciences ·B Boneu, F. Dol, C. Caranobe, Piérre Siè, Georges Houin	1989	18
17	Further Studies on the Mechanisms for the Antithrombotic Effects of Sulfated Polysaccharides in Rabbits Thrombosis and Haemostasis ·Frederick A. Ofosu, F. Fernandez, Nooroldin ANVARI, C. Caranobe, F. Dol, Y Cadroy, Maurice Petitou, J Mardiguian, Piérre Siè, B Boneu	1988	17
18	Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide Journal of Cellular Physiology ·Jean‐Marc Herbert, Alexandre Guy, Isabelle Lamarche, Anne-Marie Marés, Pierre Savi, F. Dol	1997	16
19	Pharmacologic properties of a low molecular weight dermatan sulfate: comparison with unfractionated dermatan sulfate. PubMed ·F. Dol, Maurice Petitou, J C Lormeau, J Choay, C. Caranobe, Piérre Siè, Sylvie Saivin, Georges Houin, B Boneu	1990	16
20	Simvastatin inhibits myointimal hyperplasia following carotid artery injury in cholesterol-fed rabbits Blood Coagulation & Fibrinolysis ·F. Dol, Anne-Marie Marés, Jean‐Marc Herbert	1996	12

About F. Dol

F. Dol is a scholar working on Cell Biology, Hematology, Molecular Biology, Surgery and Cancer Research, having authored 36 papers that have together received 922 indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (16 papers), Glycosylation and Glycoproteins Research (9 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers), Platelet Disorders and Treatments (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Protease and Inhibitor Mechanisms (5 papers), Heparin-Induced Thrombocytopenia and Thrombosis (5 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). The work is most often cited by research in Internal Medicine (166 citations), Hematology (378 citations), Cardiology and Cardiovascular Medicine (351 citations), Genetics (98 citations) and Cancer Research (133 citations). F. Dol has collaborated with scholars based in France, India and Canada. Frequent co-authors include Jean‐Marc Herbert, Isabelle Lamarche, Piérre Siè, B Boneu, Pierre Savi, A. Bernat, D. Dupouy, Jean-P. Hérault, Jean‐Pierre Maffrand and G. Defreyn. Their work appears in journals such as Thrombosis and Haemostasis, Thrombosis Research, FEBS Letters, Journal of Pharmacology and Experimental Therapeutics and Blood Coagulation & Fibrinolysis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact